News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Goldberg Jeff Marc
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/01/2022 |
4
| Goldberg Jeff Marc (President and CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 1,884,838 options to buy
@ $1.22, valued at
$2.3M
|
|
| 12/01/2022 |
3
| Goldberg Jeff Marc (President and CEO) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 09/30/2019 |
4
| Goldberg Jeff Marc (COO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 185,122 shares
@ $16.64, valued at
$3.1M
Paid exercise price by delivering 52,973 shares
@ $16.64, valued at
$881.5k
Paid exercise price by delivering 30,016 shares
@ $16.64, valued at
$499.5k
Exercised 302,250 options to buy
@ $6.48, valued at
$2M
Exercised 83,952 options to buy
@ $6.48, valued at
$544k
Exercised 35,230 options to buy
@ $12.21, valued at
$430.2k
|
|
| 07/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/09/2019 |
4
| Goldberg Jeff Marc (COO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 30,000 shares
@ $31.71, valued at
$951.3k
Sold 20,000 shares
@ $31.7209, valued at
$634.4k
Exercised 30,000 options to buy
@ $6.48, valued at
$194.4k
Exercised 20,000 options to buy
@ $6.48, valued at
$129.6k
|
|
| 01/04/2019 |
4
| Goldberg Jeff Marc (COO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Acquired 493 shares
@ $21.5135, valued at
$10.6k
Granted 150,000 options to buy
@ $30.73, valued at
$4.6M
|
|
| 07/02/2018 |
4
| Goldberg Jeff Marc (COO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Acquired 1,398 shares
@ $14.773, valued at
$20.7k
|
|
| 04/17/2018 |
4
| Goldberg Jeff Marc (COO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 320,000 options to buy
@ $23.93, valued at
$7.7M
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|